Ono Pharmaceutical Co Ltd ADR OPHLY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $4.99
- Day Range
- $4.78–4.94
- 52-Week Range
- $4.78–6.85
- Bid/Ask
- $4.88 / $5.02
- Market Cap
- $6.88 Bil
- Volume/Avg
- 209,657 / 109,663
Key Statistics
- Price/Earnings (Normalized)
- 8.04
- Price/Sales
- 2.00
- Dividend Yield (Trailing)
- 3.62%
- Dividend Yield (Forward)
- 3.62%
- Total Yield
- 7.40%
Company Profile
Ono Pharmaceutical is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. It maintains a global business in specialty pharmaceuticals. The company breaks out its revenue of goods and products into eight segments. The vast majority of Ono's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of Ono's sales are generated in Japan, followed by the rest of Asia and Europe.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Core
- Total Number of Employees
- 3,761
- Website
- http://www.ono.co.jp
Comparables
Valuation
|
Metric
|
OPHLY
|
4502
|
4506
|
|---|---|---|---|
Price/Earnings (Normalized) | 8.04 | 15.49 | 35.13 |
Price/Book Value | 1.25 | 0.95 | 0.46 |
Price/Sales | 2.00 | 1.55 | 0.47 |
Price/Cash Flow | 7.82 | 8.05 | — |
Price/Earnings
OPHLY
4502
4506
Financial Strength
|
Metric
|
OPHLY
|
4502
|
4506
|
|---|---|---|---|
Quick Ratio | 3.19 | 0.46 | 0.33 |
Current Ratio | 3.95 | 1.06 | 0.63 |
Interest Coverage | 219.55 | 1.93 | −55.06 |
Quick Ratio
OPHLY
4502
4506
Profitability
|
Metric
|
OPHLY
|
4502
|
4506
|
|---|---|---|---|
Return on Assets (Normalized) | 15.11% | 2.86% | −15.44% |
Return on Equity (Normalized) | 17.44% | 6.13% | −40.83% |
Return on Invested Capital (Normalized) | 16.86% | 4.78% | −24.50% |
Return on Assets
OPHLY
4502
4506
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Yggshlvvmp | Ftcdd | $713.8 Bil | |
JNJ
| Johnson & Johnson | Syhwthf | Mjfp | $348.1 Bil | |
MRK
| Merck & Co Inc | Fsddptf | Vvb | $317.6 Bil | |
ABBV
| AbbVie Inc | Nfqqybfkf | Khzb | $291.6 Bil | |
AZN
| AstraZeneca PLC ADR | Sgycvqjldc | Tnlh | $209.3 Bil | |
RHHBY
| Roche Holding AG ADR | Fkvtdprkpb | Zprr | $194.3 Bil | |
NVS
| Novartis AG ADR | Shswtsw | Ypwy | $190.0 Bil | |
PFE
| Pfizer Inc | Hrgwnydy | Chq | $143.9 Bil | |
AMGN
| Amgen Inc | Wbwwyrklv | Pzzc | $141.6 Bil | |
SNY
| Sanofi SA ADR | Zzncvpl | Vgrz | $115.1 Bil |